Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer?

Hofmockel, G; Bassukas, I D; Wittmann, A; Dämmrich, J

Hofmockel, G; Bassukas, I D; Wittmann, A; Dämmrich, J.

Affiliation

Hofmockel G; Department of Urology, University of Würzburg Medical School, Germany.

Br J Urol ; 80(1): 11-7, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9240173

Subject(s)

Carcinoma, Renal Cell/metabolism; Drug Resistance, Multiple/genetics; Genes, MDR; Kidney Neoplasms/metabolism; Adult; Aged; Carcinoma, Renal Cell/pathology; Carcinoma, Renal Cell/surgery; Disease-Free Survival; Humans; Immunohistochemistry; Kidney Neoplasms/pathology; Kidney Neoplasms/surgery; Middle Aged; Multivariate Analysis; Neoplasm Staging; Nephrectomy/mortality; Retrospective Studies; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Drug Resistance, Multiple / Genes, MDR / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Br J Urol Year: 1997 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links